-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Intra-Cellular Therapies, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2012 to Q2 2024.
- Intra-Cellular Therapies, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $57K, a 57.8% decline year-over-year.
- Intra-Cellular Therapies, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $907K, a 521% increase year-over-year.
- Intra-Cellular Therapies, Inc. annual Income Tax Expense (Benefit) for 2023 was $636K, a 10500% increase from 2022.
- Intra-Cellular Therapies, Inc. annual Income Tax Expense (Benefit) for 2022 was $6K, unchanged from 2021.
- Intra-Cellular Therapies, Inc. annual Income Tax Expense (Benefit) for 2021 was $6K, a 57.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)